Establishment of novel cell lines derived from two patients with chronic myelogenous leukemia in blast crisis; IMS-BC1 and IMS-BC2 which exhibit markedly different sensitivity to apoptosis

International Journal of Hematology

Volumn 67, Issue 3, 1998, Pages 283-294

  Nagamura, Fumitaka ^a,b   Nagamura Inoue, Tokiko ^a   Tojo, Arinobu ^a   Minamihisamatsu, Masako ^c   Tanabe, Tsuyoshi ^a   Zaike, Yuji ^a   Tani, Kenzaburo ^a   Saisho, Hiromitsu ^b   Asano, Shigetaka ^a  

^a THE UNIVERSITY OF TOKYO   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD33 ANTIGEN; CD34 ANTIGEN; CYTOKINE; GROWTH FACTOR; HLA DR ANTIGEN; MICROSOMAL AMINOPEPTIDASE; RETINOIC ACID;

ADULT; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CASE REPORT; CELL GROWTH; CHROMOSOME BREAKAGE; CHRONIC MYELOID LEUKEMIA; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

EID: 0032052125     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(98)00007-3     Document Type: Article

References (33)

1. Rowley J.D. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature. 243:1973;290-293.
2. Shtivelman E., Lifshitz B., Gale R.P., Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukemia. Nature. 315:1985;550-554.
3. Mills K.I., Sproul A.M., Leibowitz D., Burnett A.K. Mapping of breakpoints, and relationship to BCR-ABL RNA expression, in Philadelphia-chromosome-positive chronic myeloid leukemia patients with a breakpoint around exon 14 (b3) of the BCR gene. Leukemia. 5:1991;937-941.
4. Mills K.I., Benn P., Birnie G.D. Does the breakpoint within the major breakpoint cluster region (M-bcr) influence the duration of chronic phase in chronic myeloid leukemia? An analytical comparison of current literature. Blood. 78:1991;1155-1161.
5. McGahon A., Bissonnette R., Schmitt M., Cotter K.M., Green D.R., Cotter T.G. BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood. 83:1994;1179-1187.
6. Bedi A., Zehnbauer B.A., Barber J.P., Sharkis S.J., Jones R.J. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood. 83:1994;2038-2044.
7. Carlesso N., Frank D.A., Griffin J.D. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J Exp Med. 183:1996;811-820.
8. Prokocimer M., Rotter V. Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages. Blood. 84:1994;2391-2411.
9. Imamura J., Miyoshi I., Koeffler H.P. p53 in hematologic malignancies. Blood. 84:1994;2412-2421.
10. Shi Y., Glynn J.M., Guilbert L.J., Cotter T.G., Bissonnette R.P., Green D.R. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science. 257:1992;212-214.
11. Deiss L.P., Feinstein E., Cohen O., Kimchi A. Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the γ interferon-induced cell death. Genes Dev. 9:1995;15-30.
12. MacDonald I., Wang H., Grand R.et al. Transforming growth factor-β1 cooperates with anti-immunoglobulin for the induction of apoptosis in group I (biopsy-like) Burkitt lymphoma cell lines. Blood. 87:1996;1147-1154.
13. Sugahara H., Kanakura Y., Furitsu T.et al. Induction of programmed cell death in human hematopoietic cell lines by fibronectin via its interaction with Very Late Antigen 5. J Exp Med. 179:1994;1757-1766.
14. Warrell R.P. Jr., Frnkel S.R., Miller W.H. Jr.et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). New Engl J Med. 324:1991;1385-1393.
15. Watanabe-Fukunaga R., Brannan C.I., Itoh N.et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol. 148:1992;1274-1279.
16. Selleri C., Sato T., Del Vecchio L.et al. Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-α in chronic myelogenous leukemia. Blood. 89:1997;957-964.
17. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989:9.31-9.58.
18. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
19. Inoue T., Tojo A., Tsuchimoto D.et al. The possible correlation between fusion pattern of BCR/ABL mRNA and clinical response to alpha-interferon in chronic myelogenous leukemia. Leukemia. 6:1992;948-951.
20. Collins S.J., Groudine M.T. Rearrangement and amplification of c-abl sequences in the human chronic myelogenous leukemia cell line K-562. Proc Natl Acad Sci USA. 80:1983;4813-4817.
21. Clarkson B., Strife A. Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment. Leukemia. 7:1993;1683-1721.
22. Wiernik P.H., Dutcher J.P., Paietta E.et al. Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acid. Leukemia. 5:1991;504-509.
23. Konopka J.B., Watanabe S.M., Witte O.N. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell. 37:1984;1035-1042.
24. Konopka J.B., Witte O.N. Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products. Mol Cell Biol. 5:1985;3116-3123.
25. Daley G.Q., Van Etten R.A., Baltimore D. Induction of chronic myelogenous leukemia in mice by the p210BCR/ABL gene of the philadelphia chromosome. Science. 247:1990;824-830.
26. Kelliher M.A., McLaughlin J., Witte O.N., Rosenberg N. Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL. Proc Natl Acad Sci USA. 87:1990;6649-6653.
27. Darnell J.E. Jr., Kerr I.M., Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 264:1994;1415-1421.
28. Kim T.K., Maniatis T. Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway. Science. 273:1996;1717-1719.
29. Arany I., Brysk M.M., Calhoun K.H., Tyring S.K. Differentiation and IFN-γ regulate WAF-1/CIP1 transcription in p53-independent and p53-dependent pathways in epithelial cells. In Vivo. 10:1996;119-123.
30. Aglietta M., Stacchini A., Severino A., Sanavio F., Ferrando M.L., Piacibello W. Interaction of transforming growth factor-beta 1 with hemopoietic growth factors in the regulation of human normal and leukemic myelopoiesis. Exp Hematol. 17:1989;296-299.
31. Arora K., Dai H., Kazuko S.G.et al. The Drosophila schnurri gene acts in the Dpp/TGFβ signaling pathway and encodes a transcription factor homologous to the human MBP family. Cell. 81:1995;781-790.
32. Warrell R.P. Jr., de Thé H., Wang Z.Y., Degos L. Acute promyelocytic leukemia. New Engl J Med. 329:1993;177-189.
33. Cornic M., Delva L., Guidez F., Balitrand N., Degos L., Chomienne C. Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in acute promyelocytic leukemia patients. Cancer Res. 52:1992;3329-3334.